Pages that link to "Q35179204"

The following pages link to OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci (Q35179204):

Displaying 43 items.

• DAnCER: disease-annotated chromatin epigenetics resource (Q24609602) (← links)
• Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old (Q28396741) (← links)
• Pathway and network approaches for identification of cancer signature markers from omics data (Q30882475) (← links)
• Functional and topological properties in hepatocellular carcinoma transcriptome (Q31059884) (← links)
• Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and network analysis (Q31147209) (← links)
• RASOnD - A comprehensive resource and search tool for RAS superfamily oncogenes from various species (Q33950892) (← links)
• Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. (Q34103390) (← links)
• Hepatitis C virus network based classification of hepatocellular cirrhosis and carcinoma (Q34228398) (← links)
• Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma (Q34530302) (← links)
• Sgo1 is a potential therapeutic target for hepatocellular carcinoma (Q35273343) (← links)
• Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma (Q36739034) (← links)
• CoReCG: a comprehensive database of genes associated with colon-rectal cancer (Q36831821) (← links)
• Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology (Q36865004) (← links)
• Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors (Q36938591) (← links)
• High-dimensional biology to comprehend hepatocellular carcinoma (Q37087376) (← links)
• Identification of potential driver genes in human liver carcinoma by genomewide screening (Q37360110) (← links)
• An overview of hepatocellular carcinoma study by omics-based methods (Q37364456) (← links)
• Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma (Q37408915) (← links)
• A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma (Q37598989) (← links)
• Evolutionary evidence of the effect of rare variants on disease etiology (Q37787322) (← links)
• Mouse models for liver cancer. (Q38083387) (← links)
• A rationalized approach to the treatment of patients infected with hepatitis B. (Q38168105) (← links)
• Network stratification analysis for identifying function-specific network layers (Q38450989) (← links)
• Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation (Q38483244) (← links)
• Identification of hepatocellular carcinoma related genes with k-th shortest paths in a protein-protein interaction network (Q42267765) (← links)
• Oncogenetic tree modeling of human hepatocarcinogenesis (Q43035203) (← links)
• Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma (Q43978568) (← links)
• Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma (Q44320637) (← links)
• Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation (Q49735252) (← links)
• Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. (Q53306403) (← links)
• Biomarkers of carcinogenicity and their roles in drug discovery and development. (Q53316445) (← links)
• Bioinformatic analysis and prediction of the function and regulatory network of long non-coding RNAs in hepatocellular carcinoma. (Q54979499) (← links)
• Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis (Q57205292) (← links)
• Interpretation of Euphorbia Kansui Stir-Fried with Vinegar Treating Malignant Ascites by a UPLC-Q-TOF/MS Based Rat Serum and Urine Metabolomics Strategy Coupled with Network Pharmacology (Q60910267) (← links)
• ZNF689 suppresses apoptosis of hepatocellular carcinoma cells through the down-regulation of Bcl-2 family members (Q84222810) (← links)
• HCCNet: an integrated network database of hepatocellular carcinoma (Q84244762) (← links)
• dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma (Q84970343) (← links)
• Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation (Q90216475) (← links)
• Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma Based on Network Pharmacology (Q90746674) (← links)
• HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas (Q91856153) (← links)
• Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation (Q92062149) (← links)
• Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma (Q92407464) (← links)
• Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma (Q99237920) (← links)